Clinical Trials Logo

Eastern Equine Encephalitis clinical trials

View clinical trials related to Eastern Equine Encephalitis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03879603 Completed - Clinical trials for Eastern Equine Encephalitis

VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults

Start date: April 2, 2019
Phase: Phase 1
Study type: Interventional

Western Equine Encephalitis Virus (WEEV), Eastern Equine Encephalitis Virus (EEEV), and Venezuelan Equine Encephalitis Virus (VEEV) are transmitted to humans by infected mosquitoes and can cause encephalitis (swelling of the brain) and other neurological manifestations, including fever, chills, discomfort, feeling sick, muscle pain and then headache, vomiting, restlessness, irritability, seizures, coma, and death. Vaccines teach the body to prevent or fight an infection. When the body learns to fight an infection, this is called an immune response. Researchers developed a vaccine against Western, Eastern and Venezuelan equine encephalitis viruses to help the body make an immune response. There are no live or killed viruses in the vaccine, so you cannot get infected with any of these 3 viruses from getting the vaccine. The experimental trivalent encephalitis vaccine, VRC-WEVVLP073-00-VP, is composed of Western equine encephalitis (WEE), Eastern equine encephalitis (EEE), and Venezuelan equine encephalitis (VEE) virus-like particles (VLP). The purpose of this study is to test three doses (6 mcg, 30 mcg, and 60 mcg) of this experimental vaccine against Western, Eastern and Venezuelan equine encephalitis viruses.

NCT ID: NCT02654509 Completed - Clinical trials for Eastern Equine Encephalitis

Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine

Start date: June 3, 2008
Phase: Phase 2
Study type: Interventional

This study is being conducted to collect safety and immunogenicity data for the Eastern Equine Encephalitis (EEE) vaccine.

NCT ID: NCT00584805 Completed - Clinical trials for Eastern Equine Encephalitis

Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine

EEE
Start date: June 3, 2008
Phase: Phase 2
Study type: Interventional

This study is designed to determine the safety and immunogenicity of Eastern Equine Encephalitis (EEE) Vaccine.